Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.20% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 8.31% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 58.33% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -0.20% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 500.00% |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | 999.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 999.37% |
| Dec 31, 2025 | 157.50% |
| Sep 30, 2025 | 1,344.44% |
| Jun 30, 2025 | 780.83% |
| Mar 31, 2025 | 13.16% |
| Dec 31, 2024 | -359.09% |
| Sep 30, 2024 | -25.99% |
| Jun 30, 2024 | -53.72% |
| Mar 31, 2024 | -49.88% |
| Dec 31, 2023 | -81.52% |
| Sep 30, 2023 | -80.89% |
| Jun 30, 2023 | -62.63% |
| Mar 31, 2023 | -58.51% |
| Dec 31, 2022 | 53.61% |
| Sep 30, 2022 | 71.95% |
| Jun 30, 2022 | 11.77% |
| Mar 31, 2022 | -65.08% |
| Dec 31, 2021 | 73.10% |
| Sep 30, 2021 | 3.70% |
| Jun 30, 2021 | 46.73% |